European Medicines Agency confirms positive benefit-risk balance for Champix

View source ↗

Summary

The EMA confirms a positive benefit-risk balance for Champix (varenicline) following ongoing safety assessments, indicating continued approval status for smokin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Champix (varenicline)